Indoco Remedies Ltd Share Price

Q: What is the share price of Indoco Remedies Ltd today?

Indoco Remedies Ltd share price as on 22 Jan 2025 is ₹287.2

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: INDOCO Small Cap ISIN: INE873D01024

As on 22 January 2025 at 18:33 IST

₹287.20

-53.80

(-15.78%)

Sell Buy

Over 1 Month

3.41%

Over 6 Months

4.63%

Over 1 Year

-7.53%

Over 3 Years

-18.17%

Indoco Remedies Ltd Summary

Close ₹ 287.20

Open ₹ 331.80

High ₹ 333.25

Low ₹ 281.30

Volume 10,85,145

Net Turnover (in ₹) ₹ 28,14,58,334.55

52Wk High ₹ 414

52Wk Low ₹ 286.60

52Wk High / Low

281.30

414

Indoco Remedies Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 3,143.41

EPS (TTM) 8.25

Book Value (BV) 123.84

Div. Yield 0.44 %

P/E (TTM) 37.01

Price/Book Value 2.76

Delivery % 15.88 %

Face Value 2

Key Ratios

PE Ratio 25.97

PB Ratio 2.69

EV to Sales 1.97

PEG Ratio -1.48

ROA 6.92

ROE 10.83

Debt-Equity 0.39

Net Profit Margin 6.51

Operating Profit Margin 15.52

Indoco Remedies Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,827.13	1,670.95	1,543.08	1,244.64	1,109.02
Total Expenses	1,702.86	1,478.15	1,306.51	1,112.65	1,080.44
Profit Before Tax	135.80	192.79	236.57	132	28.57
Profit After Tax	97	142.25	154.80	93.05	24.12
Operating Profit after Depreciation	162.29	217.82	250.71	154.26	54.83

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	976.23	736.46	623.82	613.01	633.12
Total Non Current Assets	1,190.06	844.63	712.47	692.54	708.49
Total Current Assets	954.67	813.57	773.62	622.53	563.10
TOTAL ASSETS	2,144.73	1,658.20	1,486.09	1,315.06	1,271.60
Total Shareholder's Fund	1,109.90	1,028.25	904.64	768.99	679.57

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	156.70	178.83	173.83	82.22	122.85
Net Cash used in Investing Activities	-433.20	-208.17	-121.41	-66.69	-55.93
Net Cash used in Financing Activities	280.43	22.80	-44.37	-29.87	-63.95

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,799.32	1,669.02	1,542.04	1,243.42	1,108.42
Total Expenses	1,657.62	1,477.43	1,305.81	1,112.06	1,079.72
Profit Before Tax	153.23	191.59	236.23	131.35	28.71
Profit After Tax	116.64	141.36	154.52	92.39	24.25
Operating Profit after Depreciation	178.51	216.62	250.37	153.57	54.96

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	754.28	719.66	623.70	612.89	633
Total Non Current Assets	1,060.39	847.21	714.79	694.62	710.55
Total Current Assets	900.21	812.47	772.78	621.95	561.76
TOTAL ASSETS	1,960.61	1,659.67	1,487.57	1,316.57	1,272.31
Total Shareholder's Fund	1,126.62	1,027.02	904.30	768.93	680.16

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	176.78	178.79	173.55	82.17	122.66
Net Cash used in Investing Activities	-301.70	-208.51	-121.41	-66.70	-55.95
Net Cash used in Financing Activities	122.40	22.81	-44.37	-29.83	-63.95

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	410.55	432.66	431.49	449.64	459.42
Total Expenses	398.52	392.41	383.72	400.77	396.52
Profit Before Tax	-30.96	-4.84	6.97	32.98	22.63
Profit After Tax	-28.40	-10.01	1.82	22.03	15.56
Operating Profit after Depreciation	12.88	41.81	48.80	51.53	65.25

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	372.98	396.53	401.43	445.49	449.05
Total Expenses	352.84	343.66	349.86	388.13	383.76
Profit Before Tax	-13.36	17.38	19.51	46.50	27.02
Profit After Tax	-10.23	12.79	14.95	37.56	20.01
Operating Profit after Depreciation	24.40	57.07	55.09	61.41	68.22

Indoco Remedies Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 322.15

S2 303.30

S3 289.65

Pivot 335.80

R1 354.65

R2 368.30

R3 387.15

Moving Average

20 SMA 331.95

50 SMA 326.09

100 SMA 335.98

200 SMA 332.86

Indoco Remedies Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Indoco Remedies Ltd

₹1.5/Share

Announcement Date 19 Sep 2024

Record Date 19 Sep 2024

Div Yield 75%

AGM Date: 22 Sep 2022

AGM 22/09/2022 Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Thursday 15th September, 2022 as the Record Date for determining entitlement of members to final dividend for the financial year ended 31st March, 2022. The Register of members and Share Transfer books of the Company will remain closed from Friday, 16th September, 2022 to Thursday, 22nd September, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of payment of Dividend and AGM. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09th September, 2015, we are attaching herewith the Notice of the 75th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 22.08.2022) Proceedings of 75th Annual General Meeting of Indoco Remedies Limited (As Per BSE Announcement Dated on 22.09.2022) 1) Re-appointment of M/s Gokhale & Sathe, a Firm of Chartered Accountants, (Firm Registration No. 103264W) as Statutory Auditors of the Company for the second term of 5 consecutive years. 2.) Re-appointment of Ms. Aditi Panandikar (DIN: 00179113) as Managing Director 3). Re-appointment of Mr. Sundeep V Bambolkar (DIN: 00176613) as Jt. Managing Director Link of the Webcast of 75th AGM of Indoco Remedies Limited held on 22.09.2022 Disclosure of Voting Results of the 75th Annual General Meeting of the Company held on Thursday, 22nd September, 2022 as required under Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Scrutinizers Report (As per BSE Announcement Dated on 23/9/2022)

AGM Date: 26 Sep 2023

NEWSPAPER ADVERTISEMENT - 76TH ANNUAL GENERAL MEETING TO BE HELD ON 26TH SEPTEMBER, 2023 THROUGH VIDEO CONFERENCING (VC)/OTHER AUDIO-VISUAL MEANS (OAVM) Pursuant to Regulation 42 of SEBI(LODR) Regulations, 2015, the Company has fixed Tuesday, 19th September, 2023 as the Record Date. PURSUANT TO REGULATION 30 AND 34 OF THE SEBI (LODR) REGULATIONS,2015, ENCLOSED HEREWITH NOTICE OF THE 76TH AGM AND THE ANNUAL REPORT FOR THE FINANCIAL YEAR 2022-2023 . PURSUANT TO REGULATION 34 OF SEBI (LODR)REGULATIONS 2015, ENCLOSED HEREWITH THE ANNUAL REPORT FOR THE FINANCIAL YEAR 2022-2023 THE REGISTER OF MEMBERS AND SHARE TRANSFER BOOKS OF THE COMPANY WILL REMAIN CLOSE FROM 20-09-2023 TO 26-09-2023 (BOTH DAYS INCLUSIVE) FOR THE PURPOSE OF PAYMENT OF FINAL DIVIDEND AND AGM. (As Per BSE Announcement Dated on 01/09/2023) Voting Results of 76th AGM of Indoco Remedies Limited along with the Scrutinizers Report (As Per BSE Announcement Dated on 26/09/2023)

AGM Date: 26 Sep 2024

AGM 26/09/2024 Pursuant to Regulation 42 of the Securities and Exchange Board of India (LODR) Regulations,2015, the Company has fixed Thursday,19th September, 2024 as the Record Date. (As Per BSE Announcement Dated on 30.08.2024) Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are submitting herewith the details regarding the proceedings of the 77th AGM of the Company held on Thursday, 26th September, 2024 through Video Conferencing/Other Video Visual Means (As Per BSE Announcement dated on 26.09.2024) Please find enclosed the details of Voting Results and Scrutinizers Report for the 77th AGM of the Company held on 26th September, 2024 (As per BSE Announcement dated on 27/09/2024)

Indoco Remedies Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Indoco Remedies Ltd	₹342.35	₹3,155.86
Sun Pharmaceuticals Industries Ltd	₹1,761.80	₹4,22,714.84
Divis Laboratories Ltd	₹5,818.40	₹1,54,460.24
Cipla Ltd	₹1,427.30	₹1,15,270.75
Dr Reddys Laboratories Ltd	₹1,288.45	₹1,07,511.36
Torrent Pharmaceuticals Ltd	₹3,157.60	₹1,06,862.73

Indoco Remedies Ltd News

Indoco Remedies Ltd leads losers in 'B' group

Premier Energies Ltd, Shiva Texyarn Ltd, Waaree Energies Ltd and Khandwala Securities Ltd are among the other losers in the BSE's 'B' group today, 22 January 2025.

22 Jan 2025, 02:45 pm

Indoco Remedies allots 65,700 equity shares under ESOP

21 Jan 2025, 01:25 pm

Indoco Remedies slides on recording dismal Q3 numbers in FY25

Indoco Remedies declined 1.72% to Rs 314.45 after the pharmaceutical company reported standalone net loss of Rs 10.23 crore in Q3 FY25 as against net profit of Rs 20.01 crore posted in Q3 FY24.

21 Jan 2025, 12:53 pm

Indoco Remedies announces board meeting date

On 21 January 2025

13 Jan 2025, 05:30 pm

Indoco Remedies drops as Goa unit gets OAI status from USFDA

Indoco Remedies slipped 3.63% to Rs 328.25 after the firm received official action indicated (OAI) status from the USFDA for plant II & plant III facility located at Verna Industrial Estate Area, Goa, India.

17 Dec 2024, 12:00 pm

Indoco Remedies Ltd Stock Analysis

Annual revenue for Indoco Remedies Ltd increased by 7.81% to ₹1,799.32 crore in FY 2024 from ₹1,669.02 crore in FY 2023.
Annual Net Profit for Indoco Remedies Ltd decreased by 17.49% to ₹116.64 crore in FY 2024 from ₹141.36 crore in FY 2023.
Promoter Shareholding in Indoco Remedies Ltd increased by 0.07% in the most recent quarter, from 58.75% in September 2024 to 58.80% in December 2024.
Indoco Remedies Ltd delivered a 1-year return of -7.53% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Indoco Remedies Ltd share price moved down by 15.78% from its previous close of INR ₹341. The latest Indoco Remedies Ltd share price is INR ₹287.20.
Indoco Remedies Ltd share price today has been at a low of 281.30 and a high of 333.25. Over the past 52 weeks, the Indoco Remedies Ltd share price has seen a low of 281.30 and a high of 414.